These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 576505)

  • 1. [Influence of radiopaque substance and concentration of contrast media as well as time of infusion on excretion of contrast medium and incidence of side effects (author's transl)].
    Schmerwitz W; Rösch E
    Rontgenblatter; 1977 Feb; 30(2):71-8. PubMed ID: 576505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Injection cholecystography--influence of radiopaque substance and injection time on the excretion of contrast media and incidence of side effects].
    Schmerwitz W
    Rontgenblatter; 1977 Feb; 30(2):64-70. PubMed ID: 576504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A contribution to the rate of side-effects of hepatotropic contrast media. A clinical comparative study of iodoxamate (Endomirabil) and ioglycamid (Bilivistan) (author's transl)].
    Kölling K; Hoenle R; Korsten FW
    Radiologe; 1977 Feb; 17(2):70-3. PubMed ID: 322198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the biliary excretion of the hepatotropic contrast media ioglycamate and iotroxinate in pigs and men (author's transl)].
    Klapdor R; Aban Y; Sepehr H; Scherer K
    Rontgenblatter; 1978 Feb; 31(2):114-9. PubMed ID: 635378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tolerance and contrast density in intravenous cholangiography and cholecystography using a new contrast medium (author's transl)].
    Siemers M; Schäfer K; Menges G; Horst H
    Rontgenblatter; 1978 Oct; 31(10):596-9. PubMed ID: 581525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experiences with iodoxamic acid in the cholecystography-cholangiography (author's transl)].
    Keiner F
    Med Klin; 1976 Oct; 71(44):1885-90. PubMed ID: 1036604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results and tolerability of infusion cholegraphy using ioglycamide-85 (12.75 g meglumine salt in 75 ml) in comparison with the use of a hypotonic adipiodone solution (10 g meglumine salt in 100 ml)].
    Ronneburg HP
    Radiol Diagn (Berl); 1990; 31(3):253-60. PubMed ID: 2367631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Quality of roentgenological visualization and tolerance of various intravenous cholegraphic contrast media (author's transl)].
    Tischendorf P
    Rontgenblatter; 1980 Nov; 33(11):581-7. PubMed ID: 7003680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with a new intravenous contrast medium, BC-17 in cholecystography and cholangiography (author's transl)].
    Inamoto K; Miyoshi K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Oct; 34(10):725-34. PubMed ID: 4533780
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics and plasma albumen binding of iotroxic acid (Biliscopin), iodoxic acid (Endomirabil) and ioglycamine (Biligram) (author's transl)].
    Taenzer V; Speck U; Wolf R
    Rofo; 1977 Mar; 126(3):262-7. PubMed ID: 139346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intravenous cholangio-cystography during childhood (author's transl)].
    Fahr K; Oppermann HC; Willich E
    Rofo; 1977 Jun; 126(6):571-6. PubMed ID: 142722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse reactions to intravenous cholangiography with Biligram.
    Hald JK
    Eur J Radiol; 1984 Aug; 4(3):196-7. PubMed ID: 6468411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cholangiography and cholecystography with a new water-soluble contrast medium (BC-17) by intravenous drip infusion (II). Effects on tests of thyroid function (author's transl)].
    Tanimura H; Ishii K; Fujimura M; Matsuda M
    Nihon Geka Hokan; 1974 Nov; 43(6):476-85. PubMed ID: 4480399
    [No Abstract]   [Full Text] [Related]  

  • 14. [A new bile contrast in pediatrics (author's transl)].
    Fahr K; Oppermann HC; Willich E
    Monatsschr Kinderheilkd (1902); 1978 Jun; 126(6):391-4. PubMed ID: 661834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experiment compared between iodoxamidic acid and ioglycamic acid, in flasks drop by drop. Observations of adverse reactions].
    Viviani G; Mozzanica C; Pozzoli P
    J Radiol Electrol Med Nucl; 1975; 56 suppl 2():548. PubMed ID: 1243924
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous cholangiocholecystography using ioglycamide--indications and value].
    Wujciak D; Weingärtner R; Illmann E; Baars HG
    Radiol Diagn (Berl); 1990; 31(3):247-51. PubMed ID: 2367630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern X-ray contrast media applicable to intravenous cholangiocholecystography (review of the literature)].
    Sviridov NK; Popova ZP; Varfolomeeva VN; Mikhaĭlova NA
    Farmakol Toksikol; 1981; 44(2):245-7. PubMed ID: 7023971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dose-effects of the contrast medium Iotroxinate on biliary excretion of contrast media during infusion cholegraphy (author's transl)].
    Klapdor R
    Rofo; 1978 Aug; 129(2):215-6. PubMed ID: 151018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drip infusion cholecysto-cholangiography with iodoxamate (BC-17) (III). Especially, compared with iodipamide (author's transl)].
    Tanimura H; Takenaka M; Setoyama M; Kamata T
    Nihon Geka Hokan; 1977 May; 46(3):313-25. PubMed ID: 578092
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cholecystocholangiography via short-term infusion of iodoxamate (author's transl)].
    Maier W
    Rontgenblatter; 1981 Jan; 34(1):20-3. PubMed ID: 6894039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.